Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001828316-26-000031
Filing Date
2026-06-04
Accepted
2026-06-04 06:09:10
Documents
3
Period of Report
2026-06-04

Document Format Files

Seq Description Document Type Size
1 6-K pharmingannouncesusfdaacce.htm 6-K 40098
2 logo_greyxoriginalxa.jpg GRAPHIC 115057
3 logo_pharmingxoriginala.jpg GRAPHIC 18043
  Complete submission text file 0001828316-26-000031.txt   212174
Mailing Address DARWINWEG 24 LEIDEN P7 2333 CR
Business Address DARWINWEG 24 LEIDEN P7 2333 CR 31 (0)71 5247 400
Pharming Group N.V. (Filer) CIK: 0001828316 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39822 | Film No.: 261063120
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)